Prepubertal 27-day-old female rats maintained in a 14L:10D cycle (lights on 06:00 h) were injected s.c. at 13:00 h with saline or 2, 20 or 200 \g=m\g6-methoxy-2\x=req-\ benzoxazolinone (6-MBOA) and killed 25\p=n-\27h later. No significant differences in body, pituitary or ovarian weight were noted. Differences in uterine weight (mg/100 g body weight) and in circulating free thyroxine index fit the pattern of a reduction after the lower doses with reversal of this effect after the highest dose. A dose-related rise in plasma prolactin concentration was accompanied by a significant increase in pituitary prolactin at the lowest (2 \g=m\g) dose.
Introduction 6-Methoxy-2-benzoxazolinone (6-MBOA), a plant-derived non-oestrogenic cyclic carbamate, stimulates reproduction in montane meadow voles (Microtus montanus) in field and laboratory conditions Berger et al, 1981) . The compound is found in spring grass sprouts and is thought to trigger reproductive activity by initiating ovarian cyclicity in overwintering adult and subadult female voles. In regions where the growing season varies from year to year, the presence of 6-MBOA may serve as an important environmental cue for reproductive activity to ensure optimal survival of litters born at this time (Epstein et al, 1986) . Previous studies have shown that injections or feeding of 6-MBOA stimulate the reproductive tract of the female vole leading to increased weight of the ovaries and uteri and increased numbers of large antral follicles, litters and young (Sanders etal, 1981; Bergeri?/«/., 1981 Bergeri?/«/., , 1987 .
The hormonal mechanisms by which 6-MBOA administration induces the rapid changeover from the prepubertal state to a cyclic adult have only been explored in female rats (Butterstein et al, 1985) and gilts (Guthrie et al, 1984) and not at all in males. Butterstein et al. (1985) observed that a single injection of 6-MBOA in prepubertal female rats had no effect on LH but elevated serum FSH concentrations and ovarian weight. Extended treatment with 6-MBOA also increased gonadal weight and the number of corpora lutea. In the present set of experiments, we have investi¬ gated further the effects of 6-MBOA injections and/or pellets on potential afternoon surge concen¬ trations of plasma and pituitary LH and FSH in prepubertal female rats and have extended the observations to include prolactin and thyroid hormone concentrations. Additionally, we examined the reproductive and hormonal effects of 6-MBOA pellets in prepubertal male rats.
Materials and Methods
Animals. Prepubertal Sprague-Dawley male and female rats (Harlan, Houston, TX) arrived in our facility at 23 days of age. They were maintained throughout the experiments under controlled photoperiod (14 h light: 10 h dark; 14L: 10D; lights on 06:00 h) and temperature conditions (22 ± 2°C) and were given food (Tech Lab Chow, Winfield, Iowa) and water ad libitum. At 27 days of age, they were separated into two experimental protocols as outlined below. At the termination of each experiment the rats were weighed and quickly decapitated. Weights of the anterior pituitary and reproductive tracts (ovaries and uteri from females; testes, ventral prostates and accessory organs from males) were recorded. Plasma and anterior pituitary samples were maintained at -70°C until assayed for hormones. Preparation of injections and pellets. 6-MBOA was purchased from Chem-Biochem (Lot J4CGA025, Salt Lake City, UT). For injections 6-MBOA was dissolved in warm 100% propylene glycol and then diluted with 015 M-NaCl so that the final mixture contained 95% saline:5% propylene glycol (v:v). For the pellets, 6-MBOA was mixed with 24 mg softened beeswax. Blank beeswax or 6-MBOA pellets were implanted subcutaneously on the back of ether-anaesthetized rats.
Experimental protocols. In Exp. 1, 4 groups (8/group) of 27-day-old female rats were given a s.c. injection of diluent or 2, 20 or 200 pg 6-MBOA at 13:00 h. Rats were killed between 14:00 and 16:00 h on Day 28. In Exp. 2, 3 groups of male and female (8/group) 27-day-old rats were given implants on the morning of Day 27 with beeswax pellets or with wax pellets that contained 100 pg or 1 mg 6-MBOA. The rats were decapitated on Day 30 between 14:00 and 16:00 h.
Assays. Luteinizing hormone (LH), follicle-stimulating hormone (FSH) and prolactin were measured in duplicate by double-antibody radioimmunoassays using reference preparations, standards and hormone for iodination pro¬ vided by the National Institute of Arthritis, Digestive Diseases and Kidney (NIADDK). Thyroxine and triiodothyro¬ nine were measured by commercial kits from Diagnostic Products (Los Angeles, CA) using tubes provided with immobilized antibody. An inverse index of the fraction of thyroxine or triiodothyronine bound to plasma proteins was ascertained by determining the proportional triiodothyronine uptake (Diagnostic Products kit) in vitro from plasma onto immobilized antibody. Free thyroxine and triiodothyronine indices were obtained by calculating the product of the respective total thyronine concentration and the triiodothyronine uptake value. All samples for a given hormone were assayed together and intra-assay variation for all hormones was less than 10%.
Statistical analysis. Differences according to dose as a source of variation were assessed by ANOVA. If that was significant, the effect of dose was confirmed and characterized by comparisons of means (Student-Newman-Keuls test) or, in Exp. 1, by linear and quadratic regression against log dose or regression against the exponential of dose. In Exp. 2, there were too few dose levels to test meaningfully by regression the effect of dose beyond the results of the ANOVA and subsequent comparisons of means. The statistical principles and techniques are discussed in detail elsewhere (Dixon, 1983) .
Results
In Exp. 1, a single injection of 2, 20 or 200 µg 6-MBOA had no effect on absolute uterine weights or iody weight; however, the best-fit regression line for relative uterine weights (mg/100 g body eight) was significant (P < 001) and demonstrates an inhibitory effect of low doses (2 or 20 µg) of d MBOA and a return to near control levels with the highest (200 µg) dose (Fig. 1 ). Absolute (Table  1 or 
was observed on pituitary LH or FSH concentrations or on circulating concentrations of LH, FSH, thyroxine, triiodothyronine, triiodothyronine uptake or the calculated free index of triiodothyro¬ nine concentrations (Table 1) . However, the best-fit regression line of the free thyroxine index was significant (P < 005) and consistent with a depression at lower doses and significant negation of this effect at the 200 µg dose (Fig. 1) . A dose-related rise in plasma prolactin concentration (P < 0-01) was observed and this was accompanied by a significant increase in pituitary prolactin content at the lowest (2 µg) dose (Fig. 1) . The presence of an implanted 6-MBOA pellet in female rats in Exp. 2 had no effect on body, ovarian or uterine weight; pituitary weights were significantly elevated (P < 005) in rats treated with the highest (1 mg) dose of 6-MBOA (Table 3) . Pituitary LH and FSH and circulating concen¬ trations of LH, FSH (Table 3) , thyroxine and free thyroxine index (Fig. 2) were unaffected in the females with 6-MBOA implants. However, pituitary concentrations of prolactin were signifi¬ cantly depressed in females implanted with 1 mg 6-MBOA while plasma values were apparently unaffected (Fig. 2) . Animals implanted with a pellet containing 100 µg 6-MBOA had significantly elevated circulating triiodothyronine, free triiodothyronine index (Fig. 2 ) and triiodothyronine/ thyroxine ratio (Table 3 ) that were all approximately double the respective means of the controls with blank pellets or the animals receiving 1 mg pellets. No significant differences in absolute or relative (mg/100 g body weight) weights of pituitary, testes or accessory organ (coagulating glands + seminal vesicles) weights were observed in male rats implanted with either dose of 6-MBOA although body weights were lower in animals receiv¬ ing the lowest dose of 6-MBOA. Absolute ventral prostate weights were lower in rats receiving 100 µg 6-MBOA but when expressed relative to their already low body weights, this significance disappeared. No changes were observed in pituitary or plasma concentrations of LH (Table 2) . However, males implanted with 100 µg 6-MBOA had higher pituitary prolactin concentrations with no detectable effect of the drug on circulating prolactin values (Fig. 3) . The highest dose of 6-MBOA was associated with elevations in triiodothyronine, free triiodothyronine index, free thyroxine index and the triiodothyronine/thyroxine ratio (Fig. 3 ; Table 2 ).
Discussion
The maturation of the neuroendocrine-reproductive axis in the female rat has been divided into distinct developmental phases and the juvenile stage (Days 21-32) is pertinent to the present discussion. This phase in the female is marked by declining serum FSH and low LH concentrations, rising serum prolactin and growth hormone values, and increases in LH recep¬ tors and intraovarian oestradiol ; such changes result in a gradual increase in steroidal responsiveness to gonadotrophins. Serum prolactin concentrations during this stage nor¬ mally rise in the afternoon (Ojeda et al, 1976) . Increased prolactin is known to hasten pubertal development in rats as demonstrated by studies in which prolactin was injected s.c. or implanted into the median eminence or in which chronic hyperprolactinaemia was induced by administration of sulpiride, a dopamine blocker (Clemens et al, 1969; Wuttke et al, 1976 ; Advis & Ojeda, 1978) ; however, hypoprolactinaemia induced by treatment with bromocriptine, a dopamine agonist, delays the onset of puberty . In the present studies of juvenile female rats, a single injection of 6-MBOA induced a dose-related rise in plasma prolactin detected 25 h later. Pellets containing 6-MBOA depressed pituitary prolactin values but lack of an effect on circulating concentrations suggests that any effect of 6-MBOA on prolactin at this stage in this species is incon¬ sistent or conforms to a pattern not yet clarified. However, prolactin appears to be a key hormone in the advancement of puberty in rats, as mentioned above, and whether an environmental (dietary) compound like 6-MBOA might exert its effects on puberty in wild species partly through a pro¬ lactin mechanism remains to be determined since 3 days of treatment with 6-MBOA were sufficient to elicit weight changes in the reproductive tract in voles Sanders et al, 1981) . (1985) , we failed to find organ weight changes or alterations in circulating FSH concentrations although other hormones (prolactin and triiodothyronine) were affected. Such discrepancy between the hormonal results of the two sets of experiments may be due to the time of day of injections and/or death since this information was not given in the paper by Butterstein et al. (1985) . Alternatively, the 14L:10D photoperiod used in the present study may have provided some overriding environmental cue not present in the experiments of Butterstein et al. (1985) . Another source of variation between the two experiments concerned the type of pellet (Silastic or beeswax) used in the implantation experiment. The modicum of effect in our organ weight data appears to be in an inhibitory direction with some doses of 6-MBOA in females (Fig. 1 , relative uterine weights) rather than the stimulatory effects observed in the same dose range in a wild species Ginther et al, 1985) and in rats (Butterstein et al, 1985) . Sanders et al. (1981) examined a wide range of concentrations of 6-MBOA on uterine weight in montane voles (Microtus montanus) and noted that the threshold response occurred at 001 µg/day, became maximal at 5 µg/day, and was slightly inhibitory at the highest dose tested (200 µg/day). Our injection data might indicate an inhibitory effect at the lowdose end of the dose-response curve rather than at the high-dose end as reported by Sanders et al (1981) . However, adequate comparison of doses between our experiments and other studies is restricted by the unknown rate of exit of 6-MBOA from the subcutaneous pellets.
Morphological and hormonal changes associated with pubertal development in the male rat are grouped into several phases: infantile (7-21 days), juvenile (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) days), early pubertal (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) days), pubertal (45-60 days) and adult phases . In the juvenile stage serum gonadal steroids, gonadal responsiveness and serum prolactin concentrations are increasing and the sensitivity to steroid negative feedback is still high . It is during this stage that the serum FSH values are maximally elevated and, together with prolactin, induce an increase in testicular LH receptors (Negro-Vilar et al, 1973; Ketelslegers et al, 1978; Piacsek & Goodspeed, 1978; Zipf et al, 1978) . In the present experiment, pellets of 6-MBOA increased pituitary concen¬ trations of prolactin in males (100 µg dose). However, undetectable changes in circulating pituitary hormones, though measured at a single timepoint, suggest absence of major stimulation of the pubertal process in these males induced during the 3-day period of exposure to 6-MBOA. Several histological studies have indicated, and physiological studies corroborated, that thyroid output is maximal during early puberty and diminishes with age (Lansing & Wolfe, 1944; Grad & Hoffman, 1955; Kumaresan & Turner, 1966; Azizi, 1979) . In rats, overall mean concentrations of circulating triiodothyronine and thyroxine peak during the 1st and 2nd months of age in both sexes and then decline (Segal et al, 1982) . The occurrence of high thyronine concentrations during the pubertal period might be simply the coincident maturation of two independent neuroendocrine systems. Similarly, the observed enhancement of triiodothyronine concentrations in the present experiment may not be directly facilitatory to pubertal development. Evidence for this is drawn from human studies in which primary hypothyroidism (but not hyperthyroidism) may cause sexual precocity (Blizzard et al, 1972) . Two hypotheses, which may need to be evaluated further, are whether the maturation of the two systems is linked in this species or whether high concentrations of triiodothyronine during puberty might indirectly facilitate the onset of ovarian cyclicity. In either case, the enhancement of triiodothyronine levels by 6-MBOA treatment could be involved in the mechanism to advance puberty in animals which are more sensitive to 6-MBOA. Whether longer treatment would advance puberty even in the rat through prolactin, thyroid, or other mechanisms is not known.
Considering that ingestion of plants that contain 6-MBOA is the normal route by which various species would come into contact with this compound in their natural habitat and that 6-MBOA activity is highest in early spring shoots and decreases throughout the growing season (Epstrin et al, 1986), one could envisage a scheme in which the higher triiodothyronine levels are an ioti j;ral part of the overall reproductive process set in motion by 6-MBOA. The overwintering population of a species must provide the first litters in the new spring and it is this group of animals along with these early litters that would consume the food sources highest in 6-MBOA and form the nucleus of the breeding population for a given year. Thus, 6-MBOA would elevate triiodothyronine concen¬ trations and thereby increase general metabolic activity and, presumably, foraging behaviour which in turn would lead to increased caloric intake, increased fitness and, ultimately, to an earlier but possibly more productive reproductive performance. Such a scheme could be utilized to design further experiments.
